🇺🇸 FDA
Patent

US 10639289

Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction

granted A61KA61K31/215A61K31/351

Quick answer

US patent 10639289 (Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/215, A61K31/351, A61K31/437, A61K31/4375